Dental Anxiety and Pain During Inferior Alveolar Nerve Block in Children: the Effects of Two Distraction Techniques

NCT ID: NCT06788301

Last Updated: 2025-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

158 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-20

Study Completion Date

2023-04-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objectives: To compare the effectiveness of virtual reality (VR) and external cooling and vibration distraction techniques on dental anxiety and pain in children during inferior alveolar nerve block (IANB).

Materials and Methods: This randomized controlled parallel arm trial included 120 children aged between 6-12 years old who required IANB. Children were randomly divided following three groups: Group I: VR eyeglasses, Group II: Buzzy® device, and Group 3: Control (conventional behavior management technique). Dental anxiety levels were measured by the pulse rate and oxygen saturation level before, during, and after IANB procedure. Pain perception during IANB procedure was assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) Scale, Wong Baker Faces Scale (WBS), and Visual Analog Scale (VAS).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study was designed as a three-arm parallel randomized controlled trial to compare the effects of virtual reality (VR) and external cooling and vibration on dental anxiety and pain during inferior alveolar nerve block (IANB) in children aged 6 to 12 years old.

The sample size consisted of 120 children, and the patients were randomly divided following three different groups: Group I: VR eyeglasses group, Group II: Buzzy® device group, and Group III: Control group.

Group I (VR eylasses): In the present study, 3D VR eyeglasses (Oculus Quest 2, Oculus Go, Facebook Technologies, Auburn, USA) were used for VR distraction.

Group II (Buzzy® device): In the present study, the Buzzy® device (MMJ Labs, Atlanta, GA, USA), consisting of a bee-shaped vibrating body and removable wing-shaped cold gel packs, was used for external cooling and vibration application.

Group III (Control): In the present study, group III received conventional behavior management technique (tell-show-do) during the administration of IANB.

Administration of IANB: The oral mucosa was dried with air-water spray and topical anesthetic solution (Vemcaine %10 Lidocaine, VEM Co. Ltd., Istanbul, Turkey) was applied to the dry mucosa with a cotton pellet for 1 minute. The patient was asked to open his/her mouth as wide as possible, and then IANB was administred using 2 ml of 4% articaine with 1:100.000 adrenaline (Ultracaine DS® Forte, Sanofi Health Products Co. Ltd., Istanbul, Turkey) using an automatic aspirated Aspiject® carpule syringe (RØNVIG Dental Mfg. A/S, Daugaard, Denmark) with a 35 mm 27 gauge needle at a rate of 1 ml/minute. In order to ensure standardisation, each patient received the same dosage of local anesthetic and the IANB procedure was provided by the same investigator.

Dental anxiety and pain assessment In order to evaluate physiological changes associated with anxiety, oxygen saturation (SpO2) and pulse rate (PR) values were recorded using pediatric fingertip pulse oximeter (ChoiceMMed, Beijing Choice Electronic Technology Co., Ltd, China) 1 minutes before, during, and 1 minutes after the administration of IANB.

For objective assessment of pain during the IANB procedure, the Face, Legs, Activity, Cry, Consolability (FLACC) Behavioral Pain Assessment Scale was used. The FLACC scores were assessed by another investigator not involved in the IANB procedure.

The Wong Baker Face (WBS) and the Visual Analog Scale (VAS), two commonly used and valid pain measurment scale for pediatric patients, were used to assess the self perception of pain. Both scales were explained to the patients, and they were asked to choose the facial expression (for WBS) and the number (for VAS) that best reflected their current level of pain during the IANB procedure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Anxiety Pain Distraction Methods Local Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I (VR eyeglasses)

In the VR group, patients wore a VR eyeglasses (Oculus Quest 2, Oculustm Go, Facebook Technologies, Auburn, USA) and watched a previously selected favorite cartoon during the IANB procedure.

Group Type EXPERIMENTAL

Inferior Alveolar Nerve Block

Intervention Type PROCEDURE

local anesthesia administration (inferior alveolar nerve block)

VR eyeglasses

Intervention Type DEVICE

VR eyeglasses was used to distarct patients from dental environment during inferior alveolar nerve block.

Group II (Buzzy device)

In the Buzzy device group, the Buzzy® device (MMJ Labs, Atlanta, GA, USA) was placed extra-orally on the site of IANB (right/left mandibula) during the administration of IANB.

Group Type EXPERIMENTAL

Inferior Alveolar Nerve Block

Intervention Type PROCEDURE

local anesthesia administration (inferior alveolar nerve block)

Buzzy device

Intervention Type DEVICE

Buzzy device was used to distarct patients from dental environment during inferior alveolar nerve block.

Group III (Control)

In the control group, patients received conventional behavior management technique (tell-show-do) during the administration of IANB. Prior to the IANB procedure, the instruments to be used and procedure were explained to the patient in phrases suitable for the patient's cognitive level.

Group Type OTHER

Inferior Alveolar Nerve Block

Intervention Type PROCEDURE

local anesthesia administration (inferior alveolar nerve block)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Inferior Alveolar Nerve Block

local anesthesia administration (inferior alveolar nerve block)

Intervention Type PROCEDURE

VR eyeglasses

VR eyeglasses was used to distarct patients from dental environment during inferior alveolar nerve block.

Intervention Type DEVICE

Buzzy device

Buzzy device was used to distarct patients from dental environment during inferior alveolar nerve block.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children aged between 6-12 years without any systemic disease and physical and/or mental disorders,
* Children whose behavior rating were positive and definitely positive according to the Frankl Behavior Scale (FBS),
* Children with no known allergy to any medication or local anesthetic,
* Children who had mandibular primary/permanent molar requiring dental treatment under an IANB,
* Children with no previous experience of local anesthesia.

Exclusion Criteria

* Children with systemic disease or neurological behaviour disorders,
* Children whose behavior rating were negative and definitely negative according to the FBS,
* Children with history of allergy to any medication or local anesthetic,
* Children who exhibeted any kind of dento-facial abnormality/syndrome that lead to administration of local anesthesia difficult,
* Children with previous experience of local anesthesia, and non-Turkish speaking
Minimum Eligible Age

6 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pamukkale University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Arif Bolaca

Assist. Prof. Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arif Bolaca, Dr.

Role: STUDY_DIRECTOR

Pamukkale University Faculty of Dentistry

Aybüke ipek Atik, Dr.

Role: PRINCIPAL_INVESTIGATOR

Pamukkale University Faculty of Dentistry

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pamukkale University, Faculty of Dentistry, Department of Pediatric Dentistry

Denizli, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022DİŞF003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Effect of Virtual Reality Glasses on Pain Perception
NCT07167394 ENROLLING_BY_INVITATION NA